Photo by tcwillmott from unsplash
Spinal cord injury (SCI) causes continuous neurological deficits and major sensory‐motor impairments. There is no effective treatment to enhance sensory‐motor function following SCI. Thus, it is crucial to develop novel… Click to show full abstract
Spinal cord injury (SCI) causes continuous neurological deficits and major sensory‐motor impairments. There is no effective treatment to enhance sensory‐motor function following SCI. Thus, it is crucial to develop novel therapeutics for this particular patient population. Astaxanthin (AST) is a strong antioxidant, anti‐inflammatory and anti‐apoptotic agent. In the present study, it was tested in a severe compression SCI model with emphasis on sensory‐motor outcomes, signalling pathway, along with other complications.
Journal Title: European Journal of Pain
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!